Company Description
OmniAb (NASDAQ: OABIW) is a publicly traded company in the Services-commercial Physical & Biological Research sector.
OABIW stock has declined 54.7% over the past year. Shares last traded at $0.1070.
On a trailing twelve-month basis, OmniAb reported revenue of $18.7M with net income of -$64.8M and diluted earnings per share of $-0.57. The company operates at a net profit margin of -347.0%.
This page provides a comprehensive overview of OABIW stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
OmniAb (OABIW) stock last traded at $0.1070. Over the past 12 months, the stock has lost 54.7%.
OABIW Rankings
Latest News
SEC Filings
OmniAb has filed 10 recent SEC filings, including 4 Form 4, 2 Form 10-Q, 2 Form 8-K, 2 Form DEF 14A. The most recent filing was submitted on May 7, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all OABIW SEC filings →
Financial Highlights
OmniAb generated $18.7M in revenue over the trailing twelve months, operating income reached -$69.0M (-369.5% operating margin), and net income was -$64.8M, reflecting a -347.0% net profit margin. Diluted earnings per share stood at $-0.57. The company generated -$36.5M in operating cash flow. With a current ratio of 4.02, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Short interest in OmniAb (OABIW) currently stands at 9.6 thousand shares, down 33.6% from the previous reporting period, representing 0.0% of the shares outstanding. Over the past 12 months, short interest has decreased by 33.9%.
Days to Cover History
Days to cover for OmniAb (OABIW) currently stands at 1.1 days, down 27.2% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has decreased 99.1% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.0 to 319.6 days.
OABIW Company Profile & Sector Positioning
OmniAb (OABIW) operates in the Services-commercial Physical & Biological Research sector and is listed on the NASDAQ.